ClinicalTrials.Veeva

Menu

The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) (LINA)

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Completed

Conditions

Urinary Lithiasis
NAFLD

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, ranging from pure steatosis to non-alcoholic steatohepatitis and ultimately to liver cirrhosis. In order to study the association between NAFLD and nephrolithiasis while minimizing the confounding effect of metabolic syndrome, we investigated the impact of different degrees of NAFLD severity on potential risk factors for stone formation.

Enrollment

42 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • subject >= 18 years old
  • able to sign the ICF
  • Liver biopsy with report compatible with NAFLD

Exclusion criteria

  • alchol use > 20g/die
  • other causes of liver disease
  • active neoplasm

Trial design

42 participants in 3 patient groups

NAFLD patients without liver cirrhosis (NLCs, n = 28)
NAFLD patients with liver cirrhosis (LCs, n = 14)
healthy individuals (HIs, n = 12)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems